These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

136 related articles for article (PubMed ID: 10361873)

  • 1. Effect of danaparoid sodium on proteinuria, von Willebrand factor, and hard exudates in patients with diabetes mellitus type 2.
    van der Pijl JW; Lemkes HH; Frölich M; van der Woude FJ; van der Meer FJ; Van Es LA
    J Am Soc Nephrol; 1999 Jun; 10(6):1331-6. PubMed ID: 10361873
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Danaparoid sodium lowers proteinuria in diabetic nephropathy.
    van der Pijl JW; van der Woude FJ; Geelhoed-Duijvestijn PH; Frölich M; van der Meer FJ; Lemkes HH; van Es LA
    J Am Soc Nephrol; 1997 Mar; 8(3):456-62. PubMed ID: 9071714
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Effect of danaparoid sodium on hard exudates in diabetic retinopathy.
    van der Pijl JW; van der Woude FJ; Swart W; van Es LA; Lemkes HH
    Lancet; 1997 Dec; 350(9093):1743-5. PubMed ID: 9413466
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Use of a low-molecular-weight heparinoid (danaparoid sodium) for continuous renal replacement therapy in intensive care patients.
    Lindhoff-Last E; Betz C; Bauersachs R
    Clin Appl Thromb Hemost; 2001 Oct; 7(4):300-4. PubMed ID: 11697713
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Intraoperative monitoring of danaparoid sodium anticoagulation during cardiovascular operations.
    Gitlin SD; Deeb GM; Yann C; Schmaier AH
    J Vasc Surg; 1998 Mar; 27(3):568-75. PubMed ID: 9546248
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Danaparoid sodium.
    Acostamadiedo JM; Iyer UG; Owen J
    Expert Opin Pharmacother; 2000 May; 1(4):803-14. PubMed ID: 11249517
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Use of danaparoid sodium (Orgaran) as an alternative to heparin sodium during cardiopulmonary bypass: a clinical evaluation of six cases.
    Fernandes P; Mayer R; MacDonald JL; Cleland AG; Hay-McKay C
    Perfusion; 2000 Nov; 15(6):531-9. PubMed ID: 11131218
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Prospective randomised open-label comparison of danaparoid with dextran 70 in the treatment of heparin-induced thrombocytopaenia with thrombosis: a clinical outcome study.
    Chong BH; Gallus AS; Cade JF; Magnani H; Manoharan A; Oldmeadow M; Arthur C; Rickard K; Gallo J; Lloyd J; Seshadri P; Chesterman CN;
    Thromb Haemost; 2001 Nov; 86(5):1170-5. PubMed ID: 11816702
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Cardiopulmonary bypass with danaparoid sodium and ancrod in heparin-induced thrombocytopenia.
    Kanagasabay RR; Unsworth-White MJ; Robinson G; Bevan D; Farnsworth G; Haxby EJ; Smith EE
    Ann Thorac Surg; 1998 Aug; 66(2):567-9. PubMed ID: 9725413
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Lifesaving citrate anticoagulation to bridge ineffective danaparoid [correction of to bridge to danaparoid] treatment.
    Dworschak M; Hiesmayr JM; Lassnigg A
    Ann Thorac Surg; 2002 May; 73(5):1626-7. PubMed ID: 12022563
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Efficacy and safety of danaparoid sodium (ORG 10172) in critically ill patients with heparin-associated thrombocytopenia.
    Tardy-Poncet B; Tardy B; Reynaud J; Mahul P; Mismetti P; Mazet E; Guyotat D
    Chest; 1999 Jun; 115(6):1616-20. PubMed ID: 10378558
    [TBL] [Abstract][Full Text] [Related]  

  • 12. On the prophylactic and therapeutic use of danaparoid sodium (Orgaran) in patients with heparin-induced thrombocytopenia.
    Schenk JF; Pindur G; Stephan B; Mörsdorf S; Mertzlufft F; Kroll H; Wenzel E; Seyfert UT
    Clin Appl Thromb Hemost; 2003 Jan; 9(1):25-32. PubMed ID: 12643320
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Comparing subcutaneous danaparoid with intravenous unfractionated heparin for the treatment of venous thromboembolism. A randomized controlled trial.
    de Valk HW; Banga JD; Wester JW; Brouwer CB; van Hessen MW; Meuwissen OJ; Hart HC; Sixma JJ; Nieuwenhuis HK
    Ann Intern Med; 1995 Jul; 123(1):1-9. PubMed ID: 7539233
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Danaparoid for heparin-induced thrombocytopenia: an analysis of treatment failures.
    Kodityal S; Manhas AH; Udden M; Rice L
    Eur J Haematol; 2003 Aug; 71(2):109-13. PubMed ID: 12890149
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Low molecular weight heparinoid, ORG 10172 (danaparoid), and outcome after acute ischemic stroke: a randomized controlled trial. The Publications Committee for the Trial of ORG 10172 in Acute Stroke Treatment (TOAST) Investigators.
    JAMA; 1998 Apr 22-29; 279(16):1265-72. PubMed ID: 9565006
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Pharmacokinetics of danaparoid sodium, dalteparin sodium and heparin determined by inhibitory effect on the activated coagulation factor X activity after single intravenous administration in rabbits.
    Ishida M; Nakada Y; Horiuchi M; Sakamoto F
    Arzneimittelforschung; 1998 Aug; 48(8):818-21. PubMed ID: 9748709
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Danaparoid sodium in diabetic retinopathy.
    Gambaro G
    Lancet; 1998 Feb; 351(9103):674. PubMed ID: 9500356
    [No Abstract]   [Full Text] [Related]  

  • 18. [Danaparoid (Orgaran) as an antiocoagulant for mechanical autotransfusion with Cell Saver 5 (Hemonetics)].
    von Lüpke U; Marx A; Tessmann R; Lindhoff-Last E
    Anaesthesist; 2001 Jan; 50(1):26-31. PubMed ID: 11220255
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The use of danaparoid to manage coagulopathy in a neurosurgical patient with heparin-induced thrombocytopenia type II and intracerebral haemorrhage.
    Hertle DN; Hähnel S; Richter GM; Unterberg A; Sakowitz OW; Kiening KL
    Br J Neurosurg; 2011 Feb; 25(1):117-9. PubMed ID: 20707682
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Management of heparin allergy during pregnancy with danaparoid.
    Harrison SJ; Rafferty I; McColl MD
    Blood Coagul Fibrinolysis; 2001 Mar; 12(2):157-9. PubMed ID: 11302479
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.